Beijing Konruns Pharmaceutical Co Ltd (603590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Beijing Konruns Pharmaceutical Co Ltd (603590) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥96.44 Million ≈ $14.11 Million USD) by net assets (CN¥3.49 Billion ≈ $509.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Beijing Konruns Pharmaceutical Co Ltd (603590) market capitalisation for the company's overall valuation and market capitalisation.

Beijing Konruns Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Beijing Konruns Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Konruns Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Konruns Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Beijing Konruns Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Haesung DS Co Ltd KO:195870	0.049x
King-Strong New Material Technology Co Ltd SHE:300629	-0.006x
Shore Bancshares Inc NASDAQ:SHBI	0.072x
China Chippacking Technology Co. Ltd. A SHG:688216	N/A
Mutares SE & Co. KGaA XETRA:MUX	-0.270x
Sunflag Iron And Steel Company Limited NSE:SUNFLAG	0.020x
Hangzhou AGS MedTech Co. Ltd. A SHG:688581	N/A
Lungyen Life Service TWO:5530	-0.005x

Annual Cash Flow Conversion Efficiency for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Konruns Pharmaceutical Co Ltd from 2013 to 2025. View Beijing Konruns Pharmaceutical Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.50 Billion ≈ $511.65 Million	CN¥115.68 Million ≈ $16.93 Million	0.033x	-34.19%
2024-12-31	CN¥3.43 Billion ≈ $501.36 Million	CN¥172.25 Million ≈ $25.20 Million	0.050x	-15.21%
2023-12-31	CN¥3.36 Billion ≈ $492.02 Million	CN¥199.35 Million ≈ $29.17 Million	0.059x	+58.03%
2022-12-31	CN¥3.19 Billion ≈ $466.82 Million	CN¥119.69 Million ≈ $17.51 Million	0.038x	+65.64%
2021-12-31	CN¥3.13 Billion ≈ $458.10 Million	CN¥70.91 Million ≈ $10.38 Million	0.023x	+19.61%
2020-12-31	CN¥3.08 Billion ≈ $451.28 Million	CN¥58.41 Million ≈ $8.55 Million	0.019x	-80.28%
2019-12-31	CN¥2.73 Billion ≈ $399.19 Million	CN¥262.00 Million ≈ $38.34 Million	0.096x	-9.45%
2018-12-31	CN¥2.48 Billion ≈ $363.01 Million	CN¥263.11 Million ≈ $38.50 Million	0.106x	-46.86%
2017-12-31	CN¥1.36 Billion ≈ $198.32 Million	CN¥270.49 Million ≈ $39.58 Million	0.200x	+17.77%
2016-12-31	CN¥874.92 Million ≈ $128.03 Million	CN¥148.26 Million ≈ $21.70 Million	0.169x	-39.63%
2015-12-31	CN¥683.27 Million ≈ $99.98 Million	CN¥191.80 Million ≈ $28.07 Million	0.281x	+4.59%
2014-12-31	CN¥488.02 Million ≈ $71.41 Million	CN¥130.98 Million ≈ $19.17 Million	0.268x	-48.62%
2013-12-31	CN¥313.45 Million ≈ $45.87 Million	CN¥163.72 Million ≈ $23.96 Million	0.522x	--

About Beijing Konruns Pharmaceutical Co Ltd

SHG:603590 China Biotechnology

Market Cap

$661.05 Million

CN¥4.52 Billion CNY

Market Cap Rank

#10884 Global

#2997 in China

Share Price

CN¥28.41

Change (1 day)

+0.18%

52-Week Range

CN¥28.13 - CN¥57.36

All Time High

CN¥65.00